About BioModulus
- Home
- About Us
Sirolimus (China)
Introduction
Sirolimus, also known as Rapamycin, is a highly effective antiproliferative pharmaceutical ingredient used in Drug-Eluting Balloons (DEBs) and Drug-Eluting Stents (DES). It inhibits smooth muscle cell proliferation, significantly reducing the risk of restenosis following angioplasty and vascular interventions.
Due to its proven clinical performance and long-term efficacy, Sirolimus is considered one of the most trusted active pharmaceutical ingredients for cardiovascular drug-eluting technologies.
| Details |
|---|
| Key Features |
| Pharmaceutical Grade API |
| High Purity |
| Excellent Stability |
| Proven Clinical Performance |
| Controlled Drug Release Compatibility |
| International Manufacturing Standards |
| Suitable for Advanced Coating Technologies |
| Reliable Batch Consistency |
| Applications |
| Drug-Eluting Balloons (DEB) |
| Drug-Eluting Stents (DES) |
| Coronary Intervention Devices |
| Peripheral Vascular Devices |
| Cardiovascular Drug Coating |
| Pharmaceutical Development |